• GOB-38 in Elizabethkingia anophelis: Biochemical Insights

  2026-08-26

  The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from a clinical Elizabethkingia anophelis isolate, using recombinant expression, purified-enzyme analysis, genomic investigation, and bacterial co-culture. Its broad hydrolytic profile and distinctive active-site residues help explain resistance to multiple β-lactam classes, while the co-isolation data raise important questions about resistance dissemination during polymicrobial infection.

• Imipenem as a Translational Resistance Lens

  2026-08-26

  Imipenem is more than a broad-spectrum antibacterial benchmark. Its PBP-directed mechanism, immune-response observations, and performance in resistance-focused workflows create a practical framework for linking bacterial phenotype, carbapenemase genetics, and sepsis biology. This thought-leadership guide shows translational researchers how to use Imipenem strategically while avoiding overinterpretation of in vitro, genomic, and animal-model findings.

• Fluorescence-Trackable Coatings for Magnesium Implants

  2026-08-26

  The reference study combines chitosan corrosion control with NaYF4:Yb,Er upconversion nanoparticles to create an AZ31 magnesium interface that can be optically monitored during degradation. Its coated alloys reduced corrosion-related changes, supported osteogenic responses in MC3T3-E1 cells, and improved bone-regeneration indicators in a rat calvarial defect model.

• Perospirone Inhibits Kv1.5 in Coronary Smooth Muscle

  2026-08-25

  A 2025 Journal of Applied Toxicology study identifies a previously unrecognized vascular ion-channel action of Perospirone in freshly isolated rabbit coronary arterial smooth muscle cells. The drug inhibited Kv currents through a concentration-dependent, use-independent process with pharmacological evidence implicating Kv1.5, extending antipsychotic drug mechanism research into cardiovascular safety and vascular physiology.

• Reelin–SFK Signaling in Ketamine Response

  2026-08-24

  The 2021 PNAS study shows that Reelin–Apoer2–Src family kinase signaling is a permissive requirement for ketamine-induced hippocampal plasticity and antidepressant-like behavioral effects. By combining genetic deletion, pharmacological perturbation, electrophysiology, and biochemical analysis, the work provides a mechanistic framework for studying variable ketamine responsiveness without reducing the phenomenon to NMDA receptor blockade alone.

• PPACK Dihydrochloride in Thrombin Assays

  2026-08-24

  PPACK Dihydrochloride provides a high-affinity, irreversible thrombin checkpoint for separating protease-driven coagulation from platelet receptor signaling. This guide translates that property into practical assay workflows, controls, optimization steps, and interpretation strategies informed by selective P2X1 research.

• Coumestrol–TRIM3–PMAIP1 Ferroptosis in RA

  2026-08-23

  A 2026 study links Coumestrol treatment to ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes through stabilization of mitochondrial PMAIP1. The work identifies suppression of TRIM3-mediated ubiquitin–proteasome down-regulation as a mechanistic explanation for reduced synoviocyte proliferation and inflammatory cytokine production.

• HCAR3 Agonist Selectivity Revealed by Cryo-EM

  2026-08-22

  Ye et al. used cryo-EM and cAMP signaling assays to define how HCAR3 recognizes several agonists and how its binding pocket differs from HCAR2. The structures identify ligand-contact features that may guide HCAR3-focused studies of lipid metabolism while helping researchers interpret receptor selectivity and assay design.

• ZIF8 Nanotheranostics for Ultrasound-Guided TNBC Therapy

  2026-08-21

  Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted ZIF8 nanoplatform that combines ultrasound imaging, pH-responsive ciprofloxacin release, sonodynamic therapy, chemotherapy, and immune activation for triple-negative breast cancer. The study links ultrasound-triggered reactive oxygen species production with immunogenic cell death and increased CD8+ T-cell infiltration, while also identifying important translational questions about dosing, ultrasound parameters, safety, and tumor heterogeneity.

• Cyclopamine A8340 for Reliable Viability Assays

  2026-08-20

  Learn how Cyclopamine (SKU A8340) can improve experimental planning for Hedgehog pathway inhibition, viability assays, proliferation studies, and apoptosis analysis. This scenario-based guide covers dosing, DMSO compatibility, interpretation, workflow controls, and practical product-selection criteria.

• Optimized GBA1 mRNA for Gaucher Disease Therapy

  2026-08-20

  A 2026 study engineered human GBA1 mRNA by optimizing untranslated regions, codon usage, and poly(A) tails to improve glucocerebrosidase expression and persistence. The optimized mRNA restored lysosomal phenotypes in GBA1-knockout cells and produced detectable enzyme activity in mouse liver and spleen after lipid nanoparticle delivery, supporting further evaluation of mRNA therapy for Gaucher disease.

• SB-3CT for MMP9–PNN Assay Design

  2026-08-19

  SB-3CT is a selective gelatinase inhibitor for separating MMP-2 and MMP-9 activity in extracellular-matrix studies. This article translates new Adamtsl3–MMP9–perineuronal-net findings into practical assay decisions while defining what the compound can—and cannot—prove in CNS and cancer research.

• SM-102 for mRNA Delivery: Evidence and Workflow

  2026-08-19

  SM-102 is an ionizable lipid used in lipid nanoparticles for mRNA delivery, including mRNA vaccine development. Product specifications define its chemical identity, ethanol solubility, purity, and low-temperature storage requirements, while peer-reviewed evidence shows that LNP performance depends strongly on formulation composition and experimental conditions.

• Auranofin: Thioredoxin Reductase Inhibitor Guide

  2026-08-18

  Auranofin is a thioredoxin reductase inhibitor that perturbs cellular redox homeostasis and supports apoptosis-focused research. Product-reported benchmarks include an approximately 88 nM TrxR IC50, antimicrobial activity near 1.2 μM against Helicobacter pylori, and radiosensitization of murine tumor cells at 3–10 μM.

• O-GlcNAcylation in Porcine Oocyte Maturation

  2026-08-18

  The reference study identifies O-GlcNAcylation as an important regulator of porcine oocyte maturation, linking OGT activity with cytoskeletal organization, mitochondrial homeostasis, oxidative stress, and autophagy. Its findings suggest that this reversible post-translational modification helps coordinate the structural and metabolic requirements of meiotic progression, while also highlighting unanswered questions about mechanism and translational relevance.

8664 records 1/578 page Next 12345 下5页 Last page